1. Lymph Node Ratio Is a Reliable Prognostic Marker after Neoadjuvant Therapy and Pancreaticoduodenectomy for Pancreatic Cancer, but Does Not Predict the Utility of Adjuvant Therapy. (2022) Authors: Adams, A.; Carpenter, E.; Valdera, F.; O'Shea, A.; McCarthy, P.; Bader, J.; Clifton, G.; Peoples, G.; Nelson, D.; Vreeland, T. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Benefit of Adjuvant Chemotherapy Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma Depends on Response to Neoadjuvant Therapy. (2022) Authors: Valdera, F.; McCarthy, P.; Adams, A.; O'Shea, A.; Carpenter, E.; Bohan, P. Kemp; Chick, R.; Kawashima, T.; Clifton, G.; Peoples, G.; Nelson, D.; Vreeland, T. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗